Difference between revisions of "Team:Pasteur Paris"

Line 461: Line 461:
 
padding: 5px 10px;
 
padding: 5px 10px;
 
margin: 100px 450px 100px 50px;;
 
margin: 100px 450px 100px 50px;;
color: #615334;
+
color: #2d2718;
 
text-decoration: none;
 
text-decoration: none;
 
line-height: 1em;
 
line-height: 1em;
background: -moz-linear-gradient(center bottom , #DACDB1 11%, #F0E8D8 56%) repeat scroll 0 0 #F0E8D8;
+
background: -moz-linear-gradient(center bottom , #efe9af 11%, #f7f4d7 56%) repeat scroll 0 0 #f0d321;
background: -webkit-gradient(linear,left bottom,left top,color-stop(0.3, #DACDB1),color-stop(0.65, #F0E8D8));
+
background: -webkit-gradient(linear,left bottom,left top,color-stop(0.3, #efe9af),color-stop(0.65, #f0d321));
  
-moz-box-shadow: 0 0 65px #CDBE9F inset, 0 0 20px #BEAE8C inset, 0 0 3px #816F47;
+
-moz-box-shadow: 0 0 65px #efe9af inset, 0 0 20px #f7f4d7  inset, 0 0 3px #f0d321;
-webkit-box-shadow: 0 0 65px #CDBE9F inset, 0 0 20px #BEAE8C inset, 0 0 3px #816F47;
+
-webkit-box-shadow: 0 0 65px #efe9af inset, 0 0 20px #f7f4d7 inset, 0 0 3px #f0d321;
box-shadow: 0 0 65px #CDBE9F inset, 0 0 20px #BEAE8C inset, 0 0 3px #816F47;
+
box-shadow: 0 0 65px #efe9af inset, 0 0 20px #f7f4d7 inset, 0 0 3px #f0d321;
 
-moz-transition: all 0.3s ease-out;
 
-moz-transition: all 0.3s ease-out;
 
-webkit-transition: all 0.3s ease-out;
 
-webkit-transition: all 0.3s ease-out;
 
transition: all 0.3s ease-out;
 
transition: all 0.3s ease-out;
 
}
 
}
 +
 +
.multi-column2{
 +
  width:850px;
 +
  left:20px;
 +
  text-align : justify;
 +
  -moz-column-count:2;
 +
-webkit-column-count:2;
 +
-o-column-count:2;
 +
column-count:2;
 +
-moz-column-gap:20px;
 +
-webkit-column-gap:20px;
 +
-o-column-gap:20px;
 +
column-gap:20px;
 +
 +
}
 +
 +
  
 
.ex1 a:hover,
 
.ex1 a:hover,
Line 557: Line 574:
 
<li class="ABSTRACT">
 
<li class="ABSTRACT">
 
<a ><h1><center>Abstract</center></h1><center>
 
<a ><h1><center>Abstract</center></h1><center>
 
+
<div class="multi-column2">
<FONT size "25px"><p>Vector-borne (re) emerging diseases are responsible for severe epidemics worldwide. In most cases, vaccines or treatments are not available, and insecticides are the primary source for vector control. Consequently, over spraying of insecticides impacts the environment and leads to the selection of insecticide resistant mosquitoes. Therefore, we developed a novel diagnostic device, Mos(kit)o that includes a fixed or mobile mosquito trap and a biosilica cellulose composite patch from genetically modified E. coli. The design of the patch creates a multilayered matrix coated with antibodies capable of detecting a wide panel of vector-borne pathogens and insecticide resistant proteins from captured mosquitoes. Additionally, the patch will have 2D barcoded readouts, generating an environmental surveillance database. A precise map of vector hot spots will provide a better assessment and response to vector-borne diseases, assisting local health authorities with anticipating and preparing for an epidemic. Our tool will be user-friendly, safe, and applicable.</p></FONT>
+
<FONT size "25px"><p>Vector-borne (re) emerging diseases are responsible for severe epidemics worldwide. In most cases, vaccines or treatments are not available, and insecticides are the primary source for vector control. Consequently, over spraying of insecticides impacts the environment and leads to the selection of insecticide resistant mosquitoes. Therefore, we developed a novel diagnostic device, Mos(kit)o that includes a fixed or mobile mosquito trap and a biosilica cellulose composite patch from genetically modified E. coli.</br></br> The design of the patch creates a multilayered matrix coated with antibodies capable of detecting a wide panel of vector-borne pathogens and insecticide resistant proteins from captured mosquitoes. Additionally, the patch will have 2D barcoded readouts, generating an environmental surveillance database. A precise map of vector hot spots will provide a better assessment and response to vector-borne diseases, assisting local health authorities with anticipating and preparing for an epidemic. Our tool will be user-friendly, safe, and applicable.</p></FONT>
 
+
</div>
  
 
</center></a></li>
 
</center></a></li>

Revision as of 18:07, 17 September 2016